Methods and reagents for predicting clinical outcome and customizing chemotherapy in lung cancer patients

Details for Australian Patent Application No. 2009253298 (hide)

Owner PANGAEA BIOTECH, S.A.

Inventors Rosell Costa, Rafael; Taron Roca, Miguel

Agent Collison & Co

Pub. Number AU-A-2009253298

PCT Pub. Number WO2009/144154

Priority 08380167.0 30.05.08 EP

Filing date 19 May 2009

Wipo publication date 3 December 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/144154 Priority application(s): WO2009/144154

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253311-Method for producing silylfunctionalized ABA triblock copolymers on the basis of (meth)acrylate

2009253287-Method for processing a gas for reducing the carbon dioxide content thereof